Photo from Vinay Prasad/Twitter
Jul 6, 2023, 05:11
Even weak evidence 3 drugs better than 2 – Vinay Prasad
New paper this week walks through the RCT landscape in myeloma and shows poor post-protocol therapy.
As a result, there is very little evidence what the optimum sequence should be; Even weak evidence 3 drugs better than 2
For details: Click here
Source: Vinay Prasad/Twitter
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023